Cargando…
Antibiotic Treatment Shapes the Antigenic Environment During Chronic TB Infection, Offering Novel Targets for Therapeutic Vaccination
The lengthy and complicated current regimen required to treat drug-susceptible tuberculosis (TB) reflects the ability of Mycobacterium tuberculosis (Mtb) to persist in host tissues. The stringent response pathway, governed by the dual (p)ppGpp synthetase/hydrolase, Rel(Mtb), is a major mechanism und...
Autores principales: | Chuang, Yu-Min, Dutta, Noton K., Gordy, James T., Campodónico, Victoria L., Pinn, Michael L., Markham, Richard B., Hung, Chien-Fu, Karakousis, Petros C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198710/ https://www.ncbi.nlm.nih.gov/pubmed/32411131 http://dx.doi.org/10.3389/fimmu.2020.00680 |
Ejemplares similares
-
LB19. Intramuscular therapeutic immunization targeting Rel(Mtb)/MIP-3 induces immune signatures associated with better TB control in vivo compared to
por: Karanika, Styliani, et al.
Publicado: (2021) -
Intranasal Immunization with DnaK Protein Induces Protective Mucosal Immunity against Tuberculosis in CD4-Depleted Mice
por: Chuang, Yu-Min, et al.
Publicado: (2018) -
Can the duration of tuberculosis treatment be shortened with higher dosages of rifampicin?
por: Dutta, Noton K., et al.
Publicado: (2015) -
Altered Mycobacterium tuberculosis Cell Wall Metabolism and Physiology Associated With RpoB Mutation H526D
por: Campodónico, Victoria L., et al.
Publicado: (2018) -
The Nucleocapsid Protein of SARS–CoV-2: a Target for Vaccine Development
por: Dutta, Noton K., et al.
Publicado: (2020)